返回
Venus Medtech (Hangzhou) Inc.（02500.HK）價格
02500.HK 股價走勢圖
VENUS MEDTECH-B (02500.HK)
Venus Medtech (Hangzhou) Inc.
HK$0
0%
$0
盤中： Jan 28, 13:11:05 HKT
暫無資料Earnings FAQ
02500.HK 最近的每股盈餘與預期相比如何？
Venus Medtech (Hangzhou) Inc. 02500.HK 上一季度的收入表現如何？
Venus Medtech (Hangzhou) Inc. 的收入預期是多少？
Venus Medtech (Hangzhou) Inc. 的盈利品質評分是多少？
Venus Medtech (Hangzhou) Inc. 何時發布財報？
Venus Medtech (Hangzhou) Inc. 的預期收益是多少？
Venus Medtech (Hangzhou) Inc. 是否超出收益預期？
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
1.8M
每股盈餘 (TTM)
-1.62
股息收益率
--
市值
--
什麼是 VENUS MEDTECH-B？
Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. The company is headquartered in Hangzhou, Zhejiang and currently employs 605 full-time employees. The company went IPO on 2019-12-10. The firm mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The firm provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The firm's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The firm mainly conducts its businesses in the domestic market and overseas markets.